News
4d
MedPage Today on MSNAddressing Disparities in Multiple Sclerosis TreatmentThe Multiple Sclerosis Treatment Optimization Program (MSTOP) was motivated by research showing that Black and Hispanic ...
4d
MedPage Today on MSNLong-Term Benefits of Anti-CD20 Drugs in Relapsing MSThe four anti-CD20 drugs used in the U.S. to treat relapsing MS -- ocrelizumab, ofatumumab, and ublituximab (Briumvi; ...
Jennifer Pevec’s journey has mapped onto a remarkable period of explosive progress in the MS landscape, which has seen ...
Brian Compton, the managing editor/days at NHL.com was diagnosed with multiple sclerosis. It was stunning news for Brian, who ...
With the right strategies, you can ‘treat the treatment’ and use your MS medications reliably and successfully.
A new treatment option for people with multiple sclerosis (MS) could alleviate resource strains on New Zealand's health system. Medsafe has registered Ocrevus Subcutaneous, a 10-minute injection for ...
Selma Blair has revealed she's been "feeling great for about a year" after being diagnosed with multiple sclerosis in 2018.
Octave's MS disease activity test is now available across all 50 U.S. states to help guide clinicians' decisions about MS ...
1d
Onlymyhealth on MSNUnderstanding Multiple Sclerosis (MS): Why Selma Blair Said She Was ‘Thrilled’ to Get Her DiagnosisLearn about Multiple Sclerosis MS its challenges and Selma Blair’s journey to hope Discover how early diagnosis can lead to a ...
Researchers have identified a new biomarker in multiple sclerosis (MS): the thickness of the inflammatory rim surrounding ...
The 11th annual fundraiser is set for May 14 to bring together members of the MS community and raise support for programs and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results